Thrombosis Canada/LinkedIn
Dec 6, 2025, 06:25
Dr. Jeff Weitz Unpacks the Latest ROXI-VTE Trials
Thrombosis Canada shared a new post on LinkedIn:
“New episode!
We sat down with Dr. Jeff Weitz to unpack the latest ROXI-VTE trials and what the data could mean for the future of thrombosis prevention.
If you manage patients at risk of VTE, don’t miss this conversation—full of clinical insights, context, and what’s coming next.
Episode goes live across all platforms within 24 hours, but if you can wait, listen to it here.
Title: ROXI-VTE Trials Explained: Dr. Jeff Weitz on Next-Generation Thrombosis Prevention”
Get the latest with Hemostasis Today.
-
Aug 14, 2026, 23:18Claire Hills: New Paper on Immune Surveillance and Immune Evasion of Senescent Cells
-
Aug 14, 2026, 23:16Are We Overlooking What Matters Most to Women with Von Willebrand Disease? – RPTH Journal
-
Aug 14, 2026, 23:15Markus Müller: A New Base Editing Approach Targeting PCSK9 to Lower Cholesterol Levels
-
Aug 14, 2026, 23:14Chokri Ben Lamine: Avatrombopag in Hematology – Dosing and Monitoring
-
Aug 14, 2026, 23:13Bianca Rocca: PRECISE-DAPT Score Identifies Bleeding Risk After CABG in Patients With POAF
-
Aug 14, 2026, 19:04Ravi Kumar: Why Lupus Anticoagulant Predicts Clots, Not Bleeding
-
Aug 14, 2026, 18:53Veli Bakalov: The Number Every Hematologist Should Know in Polycythemia Vera
-
Aug 14, 2026, 18:41Marta Velia Antonini: Can Nitric Oxide Protect the ECMO Circuit Without Systemic Anticoagulation?
-
Aug 14, 2026, 18:30Irina Gontschar: What the Epkinly FDA Review Teaches Us About Sponsor Oversight